This research develops new ruthenium(II) complexes, revealing their structural features and potential applications.
A modular synthetic route has been developed to prepare a new series of cationic ruthenium(II) complexes with electron-withdrawing 1,2-diacylcyclopentadienyl ligands. The 2-acyl-6-hydroxyfulvenes were synthesized from cyclopentadienide and acyl chlorides and converted to Tl(I) cyclopentadienyl salts using Tl2SO4/KOH. Transmetalation with [Ru(η6-p-cymene)(μ-Cl)Cl]2 followed by PF6− metathesis gives the complexes [Ru{η5-1,2-C5H3(CO–R)2}(η6-p-cymene)][PF6] (R = t-Bu, p-Tol, p-ClC6H4, p-IC6H4) in moderate to high yields. The new compounds were characterized by NMR and IR spectroscopy; mass spectrometry and elemental analysis were performed where applicable. X-ray analysis of one of the complexes confirms that electron-deficient Cp ligands retain η5-coordination and structural planarity within Ru(II)–arene sandwich architectures, highlighting their potential utility in electronically tunable organometallic frameworks.
No takes yet. Share an insight, caveat, or question.
Pokharel et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: